Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes [PDF]
Allen, G +7 more
core
Evaluation of kidney function and damage in patients with hemophilia B-insights from the B-Natural study. [PDF]
Astermark J +6 more
europepmc +1 more source
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B. [PDF]
Reiss UM +27 more
europepmc +1 more source
Gene therapy as an innovative approach to the treatment of hemophilia B-a review. [PDF]
Wróblewska K +5 more
europepmc +1 more source
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials. [PDF]
Xue F +18 more
europepmc +1 more source
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen. [PDF]
Terasaka N, Mckeand W.
europepmc +1 more source
Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B.
Baatartsogt N +16 more
europepmc +1 more source
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025). [PDF]
Xue F +25 more
europepmc +1 more source

